Advertisement
Screener

VERACYTE, INC. (VCYT) Increase Decrease In Operating Lease Liability

2.8 / 5 stars · 68/120 Roast Me

VERACYTE, INC. Increase Decrease In Operating Lease Liability

VERACYTE, INC. (VCYT) reported Increase Decrease In Operating Lease Liability of $453.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-31

  • VERACYTE, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $772.00K.
  • VERACYTE, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$319.00K.
  • VERACYTE, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$799.00K, a 102.41% decline year-over-year.
  • VERACYTE, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$495.00K.
  • VERACYTE, INC. increase decrease in operating lease liability for fiscal 2025 was -$2.48M.
  • VERACYTE, INC. increase decrease in operating lease liability for fiscal 2024 was -$5.41M.
  • VERACYTE, INC. increase decrease in operating lease liability for fiscal 2023 was -$4.33M.
  • VERACYTE, INC. increase decrease in operating lease liability for fiscal 2022 was -$3.45M.
Period endIncrease Decrease In Operating Lease Liability 3 monthIncrease Decrease In Operating Lease Liability 6 monthIncrease Decrease In Operating Lease Liability 9 monthIncrease Decrease In Operating Lease Liability 12 month
2026-06-30$772.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$453.00K
10-Q · filed 2026-07-31
-$346.00K
derived: sum of 3 quarters · filed 2026-07-31
-$841.00K
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31-$319.00K
10-Q · filed 2026-05-06
-$1.12M
derived: sum of 2 quarters · filed 2026-05-06
-$1.61M
derived: sum of 3 quarters · filed 2026-05-06
-$2.22M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31-$799.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$1.29M
derived: sum of 2 quarters · filed 2026-02-26
-$1.90M
derived: sum of 3 quarters · filed 2026-07-31
-$2.48M
10-K · filed 2026-02-26
2025-09-30-$495.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$1.10M
derived: sum of 2 quarters · filed 2026-07-31
-$1.68M
10-Q · filed 2025-11-05
$31.52M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30-$609.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
-$1.19M
10-Q · filed 2026-07-31
$32.01M
derived: sum of 3 quarters · filed 2026-07-31
$30.53M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31-$577.00K
10-Q · filed 2026-05-06
$32.62M
derived: sum of 2 quarters · filed 2026-05-06
$31.14M
derived: sum of 3 quarters · filed 2026-05-06
$29.75M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$33.20M
10-K · filed 2025-02-28
$31.72M
derived: sum of 2 quarters · filed 2025-11-05
$30.32M
derived: sum of 3 quarters · filed 2025-11-05
-$5.41M
10-K · filed 2026-02-26
2024-09-30-$1.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$2.88M
derived: sum of 2 quarters · filed 2025-11-05
-$3.93M
10-Q · filed 2025-11-05
-$5.03M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$1.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$2.45M
10-Q · filed 2025-08-07
-$3.55M
derived: sum of 3 quarters · filed 2026-02-26
-$4.68M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$1.05M
10-Q · filed 2025-05-08
-$2.16M
derived: sum of 2 quarters · filed 2026-02-26
-$3.29M
derived: sum of 3 quarters · filed 2026-02-26
-$4.43M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$2.24M
derived: sum of 2 quarters · filed 2026-02-26
-$3.38M
derived: sum of 3 quarters · filed 2026-02-26
-$4.33M
10-K · filed 2026-02-26
2023-09-30-$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$2.27M
derived: sum of 2 quarters · filed 2024-11-07
-$3.23M
10-Q · filed 2024-11-07
-$4.10M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$1.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$2.09M
10-Q · filed 2024-08-07
-$2.97M
derived: sum of 3 quarters · filed 2025-02-28
-$3.86M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$950.00K
10-Q · filed 2024-05-08
-$1.83M
derived: sum of 2 quarters · filed 2025-02-28
-$2.72M
derived: sum of 3 quarters · filed 2025-02-28
-$3.80M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$878.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$1.77M
derived: sum of 2 quarters · filed 2025-02-28
-$2.85M
derived: sum of 3 quarters · filed 2025-02-28
-$3.45M
10-K · filed 2025-02-28
2022-09-30-$890.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$1.97M
derived: sum of 2 quarters · filed 2023-11-08
-$2.57M
10-Q · filed 2023-11-08
-$2.65M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$1.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$1.68M
10-Q · filed 2023-08-09
-$1.76M
derived: sum of 3 quarters · filed 2024-02-29
-$2.46M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$597.00K
10-Q · filed 2023-05-05
-$681.00K
derived: sum of 2 quarters · filed 2024-02-29
-$1.37M
derived: sum of 3 quarters · filed 2024-02-29
-$2.02M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$84.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$777.00K
derived: sum of 2 quarters · filed 2024-02-29
-$1.42M
derived: sum of 3 quarters · filed 2024-02-29
-$1.79M
10-K · filed 2024-02-29
2021-09-30-$693.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$1.34M
derived: sum of 2 quarters · filed 2022-11-03
-$1.71M
10-Q · filed 2022-11-03
2021-06-30-$644.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$1.02M
10-Q · filed 2022-08-03
2021-03-31-$373.00K
10-Q · filed 2022-05-04
2020-12-31-$1.41M
10-K · filed 2023-03-01
2019-12-31-$1.21M
10-K · filed 2022-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B